IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CARDANI, ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.572
EU - Europa 2.874
AS - Asia 2.574
SA - Sud America 270
AF - Africa 52
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.365
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.406
GB - Regno Unito 830
SG - Singapore 722
CN - Cina 714
IT - Italia 660
BD - Bangladesh 301
DE - Germania 289
SE - Svezia 269
HK - Hong Kong 250
BR - Brasile 194
RU - Federazione Russa 193
VN - Vietnam 186
FR - Francia 139
CA - Canada 128
NL - Olanda 108
IN - India 106
FI - Finlandia 78
UA - Ucraina 66
IE - Irlanda 59
KR - Corea 54
TR - Turchia 54
BE - Belgio 46
ID - Indonesia 43
JP - Giappone 38
ES - Italia 27
EU - Europa 26
CI - Costa d'Avorio 24
CO - Colombia 24
MX - Messico 23
PT - Portogallo 22
AU - Australia 20
AR - Argentina 17
IQ - Iraq 17
PL - Polonia 15
DK - Danimarca 13
PH - Filippine 12
TW - Taiwan 12
CH - Svizzera 11
AT - Austria 9
CL - Cile 9
UZ - Uzbekistan 9
IL - Israele 8
RO - Romania 8
VE - Venezuela 8
EC - Ecuador 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
GR - Grecia 6
PE - Perù 6
ZA - Sudafrica 5
HN - Honduras 4
JO - Giordania 4
KE - Kenya 4
MA - Marocco 4
NO - Norvegia 4
NP - Nepal 4
PK - Pakistan 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
EG - Egitto 3
HU - Ungheria 3
IR - Iran 3
MY - Malesia 3
QA - Qatar 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
ET - Etiopia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
OM - Oman 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GN - Guinea 1
HR - Croazia 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
RE - Reunion 1
RS - Serbia 1
Totale 9.386
Salva come PNG Salva come JPEG
Città #
Southend 683
Ashburn 437
Singapore 408
Chandler 333
Milan 217
Hong Kong 213
Dallas 197
San Jose 196
Beijing 132
Fairfield 114
Ann Arbor 113
Seattle 111
Los Angeles 103
Santa Clara 99
Dearborn 93
Wilmington 88
Council Bluffs 87
New York 87
Woodbridge 81
Toronto 78
Princeton 73
Frankfurt am Main 67
Dublin 59
Houston 57
Ho Chi Minh City 55
Munich 45
Cambridge 43
Hanoi 40
Jacksonville 39
Lauterbourg 37
Bengaluru 36
Shanghai 36
Boardman 35
Brussels 34
Hefei 34
Buffalo 33
Jakarta 33
Phoenix 32
Columbus 31
Guangzhou 31
Nanjing 31
São Paulo 30
The Dalles 30
Turin 30
Redwood City 29
Rome 29
Helsinki 28
Des Moines 27
Abidjan 24
Moscow 24
Boston 23
Mountain View 20
Jinan 19
London 19
Bogotá 18
Monza 18
Turku 18
Redmond 17
Tokyo 17
Serra 16
Salt Lake City 15
Cangzhou 14
Somerville 14
Bologna 13
Chicago 13
Grafing 13
Naples 13
Seoul 13
Shenzhen 13
Andover 12
Da Nang 12
Nanchang 12
Nottingham 12
Sakarya 12
Tianjin 12
Hangzhou 11
Mexico City 11
Ottawa 11
Shenyang 11
Baghdad 10
Berlin 10
Haiphong 10
Hanover 10
Pittsburgh 9
San Francisco 9
Bari 8
Harbin 8
Hebei 8
Istanbul 8
Jiaxing 8
Montreal 8
Nuremberg 8
Orem 8
Palermo 8
Paris 8
Pisa 8
Silver Spring 8
South El Monte 8
Amsterdam 7
Atlanta 7
Totale 5.600
Salva come PNG Salva come JPEG
Nome #
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2 598
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel 527
Neuropsychological and psychological functioning aspects in myotonic dystrophy type 1 patients in Italy 337
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 331
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy 314
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 299
Antibody responses to BNT162b2 mRNA vaccine: infection‐naïve individuals with abdominal obesity warrant attention 298
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2 295
Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2 293
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction 271
Circulating irisn is reduced in male patients with type 1 and type 2 Myotonic Dystrophies 266
High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy : A case-control study 260
BRAF V599E mutation occurs in Spitz and Reed nevi 251
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle 247
Effect of glucose stress conditions in BL6T murine melanoma cells 238
Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2 233
Reducing contrast agent residuals in hospital wastewater: the GREENWATER study protocol 232
Type 1 diabetes onset in Lombardy region, Italy, during the COVID-19 pandemic: The double-wave occurrence 232
Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2 229
Viral Agents and Systemic Levels of Inflammatory Cytokines in Vulnerable and Stable Atherosclerotic Carotid Plaques 226
Establishment of a cardiac biobank in a Department of Pathology and Laboratory Medicine 219
Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways 218
Plasma microRNAs as biomarkers for myotonic dystrophy type 1 214
Biomolecular diagnosis of myotonic dystrophy type 2 : a challenging approach 213
Clinical Reasoning : a 35-year-old woman with hyperstartling, stiffness, and accidental falls : a startling diagnosis 210
Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2 203
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2 189
Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia 185
RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2 : an immunocytochemical study 184
Proximal myotonic dystrophy mimicking progressive muscular atrophy 171
A putative role of ribonuclear inclusions and MBNL1 in the impairment of gallbladder smooth muscle contractility with cholelithiasis in myotonic dystrophy type 1 167
Colocalization of ribonuclear inclusions and MBNL1 foci with no impairment of muscle differentiation in DM2 166
Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers 166
Characterization of sarcoplasmic reticulum Ca2+ ATPase pumps in muscle of patients with myotonic dystrophy and with hypothyroid myopathy 164
Myotonic dystrophy type 2 and modifier genes : an update on clinical and pathomolecular aspects 163
BNT162b2 Booster Dose Elicits a Robust Antibody Response in Subjects with Abdominal Obesity and Previous SARS-CoV-2 Infection 159
Muscleblind-like protein 1 nuclear sequestration and splicing pattern in myotonic dystrophy type 2 159
Drug resistant focal epilepsy in a patient with myotonic dystrophy type 2 : casual or causal association? 153
Myotonic dystrophies : an update on clinical aspects, genetic, pathology, and molecular pathomechanisms 149
Biomechanical assessment of vulnerable plaque: from histological evidence to ultrasound elastography and image-based computational patient-specific modelling 135
Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2 112
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1 43
null 3
Viral Agents and Systemic Levels of Inflammatory Cytokines in Vulnerable and Stable Atherosclerotic Carotid Plaques 1
Totale 9.723
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022692 28 35 52 21 39 44 45 32 102 90 52 152
2022/2023904 104 130 81 119 75 119 20 52 102 28 45 29
2023/2024565 26 40 34 36 137 51 30 37 27 26 45 76
2024/20251.406 62 139 40 118 112 57 76 124 75 146 174 283
2025/20263.258 368 259 371 186 255 168 416 103 224 251 408 249
2026/2027149 149 0 0 0 0 0 0 0 0 0 0 0
Totale 9.723